BMY News

Recent headlines mentioning BMY, newest first.

BMY bullish

Bristol Myers Squibb’s Rally Has Momentum, but Can Its New Drugs Justify More Upside?

insidermonkey.com·Oct 16, 2026·Over the last year, Bristol-Myers Squibb Company (NYSE:BMY) has done better than the overall market, with its shares increasing by nearly 40% as a result of new...
BMY neutral

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com·Oct 14, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
BMY neutral

Bristol Myers (BMY) Advances IPF Treatment with Admilparant Phase III Success

gurufocus.com·Oct 12, 2026·On October 12, 2026, Bristol-Myers Squibb Co (NYSE: BMY) announced positive Phase III trial results for admilparant, a drug candidate targeting idiopathic pulmo...
BMY neutral

Bristol Myers Squibb (BMY) Reports Positive Phase 3 Trial Results for Admilparant in IPF

gurufocus.com·Oct 12, 2026·On October 12, 2026, Bristol Myers Squibb Co (NYSE: BMY) announced encouraging topline results from its pivotal Phase 3 ALOFT-IPF trial evaluating admilparant f...
BMY bullish

Bristol-Myers Squibb Stock: Balanced Segment Growth, Pullback Is An Opportunity (NYSE:BMY)

seekingalpha.com·Oct 7, 2026·Health care-sector stocks soared from May through mid-August, right in the heart of the “broadening trade” that benefited areas away from tech. Yes, it has ...
BMY neutral

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion

manilatimes.net·Oct 5, 2026·Bitmine is 99% of the way to the 'Alchemy of 5%' in just 15 months Tom Lee to deliver the keynote at Token2049 on October 7, 2026 in Singapore Bitmine was add...
BMY neutral

AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?

insidermonkey.com·Oct 4, 2026·AbbVie Inc. (NYSE:ABBV) closed at $262.82 on October 2, and Bristol Myers Squibb Company (NYSE:BMY) at $61.15. Both spent the last few years doing the same diff...
BMY neutral

Bristol Myers Squibb (BMY) Boosts Champions in Care Initiative with $1M Grants for Underserved Communities

gurufocus.com·Oct 1, 2026·On October 01, 2026, Bristol Myers Squibb Co (NYSE: BMY) announced an enhancement to its Champions in Care program, committing $1 million in grants to nonprofit...
BMY neutral

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

zacks.com·Sep 30, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
BMY neutral

Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY)

seekingalpha.com·Sep 4, 2026·Sure enough, Bristol Myers Squibb ( BMY ) has turned out to be a lovely hedge to offset AI-heavy portfolio risk so far. As things stand, the pharma behemoth has...
BMY bullish

Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY)

seekingalpha.com·Sep 4, 2026·iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity f...
BMY neutral

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

finance.yahoo.com·Sep 2, 2026·Dividend stocks can be tricky for investors. If you're looking to invest $1,000 and benefit from a stock that pays a dividend, you have to look past the stock's...
BMY neutral

NVS Looks 16.5% Overvalued on GF Value™ Amid Dividend Safety Focus

gurufocus.com·Sep 1, 2026·On September 01, 2026, Novartis AG (NYSE: NVS) announced a pause in eight clinical trials involving an experimental therapy for autoimmune and neurological diso...
BMY bearish

Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast

insidermonkey.com·Aug 21, 2026·Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 2% on Tuesday even after the telehealth company posted second-quarter revenue of $753.2 million, up 38% an...
BMY neutral

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

manilatimes.net·Aug 20, 2026·Pumitamig plus B7H3-targeting elfetabart drozuntecan delivers the first data in lung cancer for any PD-(L)1xVEGF bispecific immunomodulator combined with an ant...
BMY neutral

AstraZeneca Vs. Bristol-Myers Squibb: Who’s The Better Bargain For Investors (NYSE:BMY)

seekingalpha.com·Aug 19, 2026·With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conser...
BMY neutral

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

finance.yahoo.com·Aug 18, 2026·Want some quality dividend stocks to buy, but don't want to break the bank? The stocks listed below offer above-average yields and trade at less than $100. They...
BMY neutral

US Pharma Firms Forge Deals with Chinese Biotechs Amid Regulatory Pushback

chinamoneynetwork.com·Aug 17, 2026·This area is available only to Subscribers. Major US pharmaceutical companies are accelerating partnerships with Chinese biotech firms despite efforts to decou...
BMY bearish

BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market

rttnews.com·Aug 4, 2026·Tuesday, BioNTech SE (BNTX) announced its financial results for the second quarter, reporting a net loss of 820.8 million euros, or 3.24 euros per share, compar...
BMY bullish

Bristol-Myers Squibb Stock: Why I'm Still Bullish After Q2 (NYSE:BMY)

seekingalpha.com·Jul 30, 2026·With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conser...
BMY neutral

Gyre Therapeutics Appoints Three New Members to its Board of Directors

manilatimes.net·Jul 16, 2026·SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. ("Gyre”, "Gyre Therapeutics” or the "Company”) (Nasdaq: GYRE), an innovative, commerc...
BMY neutral

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

finance.yahoo.com·Jul 14, 2026·Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn't eliminate that pressure. It did, however, pursue v...
BMY neutral

Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect

finance.yahoo.com·Jul 9, 2026·Bristol Myers Squibb logo under a magnifying glass_ By Casimiro With a market cap of $117.5 billion, Bristol-Myers Squibb Company (BMY) is a global biopharmace...
BMY neutral

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

finance.yahoo.com·Jul 6, 2026·Bristol Myers Squibb (NYSE: BMY) belongs to an elite group. Only two other large-cap healthcare stocks offer higher dividend yields. Bristol Myers Squibb's juic...